Luteinizing Hormone

Luteinizing hormone, commonly abbreviated LH, is a biomarker classified within the sex hormones category. It is reported as a laboratory measurement, with the result presented using the unit shown alongside the marker.

Luteinizing Hormone is measured from a serum sample, meaning the test uses the liquid portion of a blood sample. Fasting is not required for this measurement, so it can generally be arranged without fasting-related preparation.

Interpretation should use the reference range appropriate to the person being tested, because the listed ranges differ for males and females. The optimal range is a narrower range within the broader reference interval; these ranges are used to provide context for the reported result rather than as a diagnosis on their own.

Luteinizing Hormone may be considered alongside Fsh, Testosterone Total, and Estradiol when reviewing related hormone results. A clinician can help determine how the result fits the reason for testing and the person’s wider clinical context.

Luteinizing Hormone results are interpreted against the reference range printed on the same report. The unit, laboratory method, and population range used by the laboratory matter, so a number should not be judged in isolation or compared with a range from another report. Ranges may also differ by sex, which is why the applicable range on the report is important.

The optimal range is narrower than the reference range. A result can therefore fall within the broader reference range while sitting outside the tighter optimal range. These are different comparison points and should not be treated as interchangeable.

A single Luteinizing Hormone value is not a diagnosis. Interpretation depends on the clinical context and the range supplied with the result. Results outside the report’s reference range should be discussed with a clinician, particularly when they occur alongside symptoms or other abnormal findings.

Luteinizing Hormone is considered optimal within a range, so a decrease is not inherently favorable and an increase is not inherently unfavorable; relevance depends on whether the starting value is above or below that range.

Trials measured this marker directly. Quercetin, Berberine, Resveratrol, and Ashwagandha were associated with decreases in Luteinizing Hormone, while Coenzyme Q10, Tribulus Terrestris, and Milk Thistle (Silymarin) were associated with increases. Vitamin E, Omega-3, Alpha-Lipoic Acid (ALA), Curcumin, Melatonin, Maca Root, and Inositol were classified as showing no overall change. These findings do not establish that a particular direction is desirable for every person.

The typical time to recheck ranged from 5.7 to 26.1 weeks across the direct measurements, so results reflect changes assessed over several weeks to months rather than an immediate response. The evidence includes both meta-analyses and randomized controlled trials, but the findings are not uniform across interventions. Interpretation is most relevant when the person’s baseline Luteinizing Hormone value, clinical context, and reason for testing are considered together; medical conditions should be discussed with a clinician.